SCHEMBL8287147

SCHEMBL8287147

CCOC(=O)c1nc2c(cc1F)c(=O)cc(Nc1cccc(F)c1)n2-c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
MAPK1 P28482 1/20 0.44
BCHE P06276 3/20 0.42
ACHE P22303 3/20 0.42
ELANE P08246 3/20 0.41
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
MAPT P10636 1/20 0.41
PTGES O14684 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CSF1R P07333 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CDC25B P30305 1/20 0.38
ALDH1A1 P00352 1/20 0.38
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872077 0.89 CSF1R (0.50) HTTBCHEACHEELANEGAA
SCHEMBL8287133 0.85 ALDH1A1 (0.43) BCHEACHEMAPTCSF1RSMN1; SMN2
SCHEMBL8286371 0.85 LMNA (0.39) MAPTCSF1RSMN1; SMN2ALDH1A1RIPK1
SCHEMBL8287801 0.79 ALDH1A2 (0.37) MAPTSMN1; SMN2ALDH1A1
SCHEMBL8286374 0.78 PDE11A (0.45) HTTMAPK1BCHEACHEMGAM
SCHEMBL8287373 0.76 PDE11A (0.40) HTTGAAMAPTCSF1RSMN1; SMN2
SCHEMBL8287383 0.75 PDE11A (0.41) MAPK1GAACSF1RSMN1; SMN2ALDH1A1
SCHEMBL8287382 0.74 PDE11A (0.43) MAPK1GAAMAPTCSF1RALDH1A1
SCHEMBL5871882 0.74 CSF1R (0.48) HTTBCHEACHEELANEGAA
SCHEMBL8285199 0.74 CSF1R (0.47) HTTGAAMAPTNPSR1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed